Investor Nikko Asset Management Americas, Inc.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Nikko Asset Management Americas, Inc. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-13 13G TXG / 10x Genomics, Inc. 5,362,656 6,009,653
2025-05-12 13G/A ARCT / Arcturus Therapeutics Holdings Inc. 2,315,294 1,926,084
2025-05-12 13G/A TXG / 10x Genomics, Inc. 6,373,212 5,362,656
2025-02-13 13G/A QSI / Quantum-Si incorporated 8,532,917 5,965,208
2025-02-13 13G/A NXDR / Nextdoor Holdings, Inc. 9,640,128 8,907,840
2025-02-13 13G/A ADPT / Adaptive Biotechnologies Corporation 7,733,884 6,833,137
2024-11-08 13G ARCT / Arcturus Therapeutics Holdings Inc. 1,320,652 2,315,294
2024-11-08 13G ADPT / Adaptive Biotechnologies Corporation 7,733,884
2024-11-08 13G/A BLDE / Strata Critical Medical, Inc. 3,974,292 3,752,818
2024-11-08 13G TXG / 10x Genomics, Inc. 6,373,212
2024-11-08 13G/A TWST / Twist Bioscience Corporation 3,583,443 2,860,847
2024-11-08 13G/A CDNA / CareDx, Inc 2,874,899 1,652,759
2024-02-13 13G QSI / Quantum-Si incorporated 8,532,917
2024-02-13 13G/A PD / PagerDuty, Inc. 5,361,415 4,365,408
2024-02-13 13G/A TDOC / Teladoc Health, Inc. 8,125,231 7,464,874
2024-02-13 13G KIND / Nextdoor Holdings, Inc. 9,640,128
2024-02-13 13G/A BLDE / Strata Critical Medical, Inc. 4,841,415 3,974,292
2024-02-13 13G/A NVTAQ / Invitae Corporation 17,256,161 16,764,480
2024-02-12 13G/A CRSP / CRISPR Therapeutics AG 4,006,476 3,369,762
2024-02-12 13G/A ONVO / Organovo Holdings, Inc. 454,752 0
2024-02-12 13G/A ARCT / Arcturus Therapeutics Holdings Inc. 1,449,060 1,320,652
2024-02-12 13G/A TWOU / 2U, Inc. 5,517,725 5,296,327
2024-02-12 13G/A TWST / Twist Bioscience Corporation 2,934,033 3,583,443
2024-02-12 13G/A ROKU / Roku, Inc. 7,511,858 5,636,483
2024-02-12 13G CDNA / CareDx, Inc 2,874,899
2024-02-12 13G/A PACB / Pacific Biosciences of California, Inc. 14,166,193 13,200,375
2024-02-12 13G/A PATH / UiPath Inc. 27,204,205 21,551,233
2023-02-10 13G/A ARCT / Arcturus Therapeutics Holdings Inc. 1,357,472 1,449,060
2023-02-10 13G/A BLDE / Strata Critical Medical, Inc. 4,332,774 4,841,415
2023-02-10 13G/A CERS / Cerus Corporation 11,529,716 7,171,280
2023-02-10 13G/A ONVO / Organovo Holdings, Inc. 478,570 454,752
2023-02-10 13G/A NVTAQ / Invitae Corporation 18,998,453 17,256,161
2023-02-10 13G/A NIU / Niu Technologies - Depositary Receipt (Common Stock) 4,248,698 3,377,939
2023-02-10 13G/A PACB / Pacific Biosciences of California, Inc. 11,915,025 14,166,193
2023-02-10 13G/A CGEN / Compugen Ltd. 6,998,382 0
2023-02-10 13G PATH / UiPath Inc. 27,204,205
2023-02-10 13G/A CRSP / CRISPR Therapeutics AG 4,319,471 4,006,476
2023-02-10 13G ROKU / Roku, Inc. 7,511,858
2023-02-10 13G/A SSYS / Stratasys Ltd. 4,501,549 1,683,313
2023-02-10 13G/A TDOC / Teladoc Health, Inc. 8,755,058 8,125,231
2023-02-10 13G/A TWOU / 2U, Inc. 5,273,261 5,517,725
2023-02-10 13G/A PD / PagerDuty, Inc. 6,178,820 5,361,415
2023-02-10 13G TWST / Twist Bioscience Corporation 2,934,033
2022-02-14 13G ARCT / Arcturus Therapeutics Holdings Inc. 1,357,472
2022-02-14 13G/A NTLA / Intellia Therapeutics, Inc. 5,104,362 2,753,903
2022-02-14 13G/A CGEN / Compugen Ltd. 7,028,228 6,998,382
2022-02-14 13G NIU / Niu Technologies - Depositary Receipt (Common Stock) 4,248,698
2022-02-14 13G TDOC / Teladoc Health, Inc. 8,755,058
2022-02-14 13G/A PRLB / Proto Labs, Inc. 1,590,665 911,615
2022-02-14 13G/A CLXT / Calyxt Inc 2,275,265 1,326,256
2022-02-14 13G/A CRSP / CRISPR Therapeutics AG 3,836,823 4,319,471
2022-02-14 13G/A EDIT / Editas Medicine, Inc. 4,388,143 2,675,235
2022-02-14 13G/A TREE / LendingTree, Inc. 1,141,653 0
2022-02-14 13G/A SSYS / Stratasys Ltd. 4,152,236 4,501,549
2022-02-14 13G/A PD / PagerDuty, Inc. 8,715,876 6,178,820
2022-02-14 13G/A US3021041047 / ExOne Co 1,457,036 0
2022-02-14 13G/A TWOU / 2U, Inc. 6,272,370 5,273,261
2022-02-14 13G/A MTLS / Materialise NV - Depositary Receipt (Common Stock) 2,655,198 2,640,699
2022-02-14 13G/A NVTA / Invitae Corporation 11,255,614 18,998,453
2022-02-14 13G PACB / Pacific Biosciences of California, Inc. 11,915,025
2022-02-14 13G/A ONVO / Organovo Holdings, Inc. 478,570 478,570
2022-02-14 13G/A MCRB / Seres Therapeutics, Inc. 5,823,603 785,519
2022-02-14 13G/A VCYT / Veracyte, Inc. 3,272,038 3,121,103
2022-02-14 13G/A SYRS / Syros Pharmaceuticals, Inc. 4,381,992 0
2022-02-14 13G BLDE / Strata Critical Medical, Inc. 4,332,774
2022-02-14 13G/A CERS / Cerus Corporation 11,103,210 11,529,716
2021-05-07 13G/A PD / PagerDuty, Inc. 6,359,550 8,715,876
2021-02-11 13G/A SYRS / Syros Pharmaceuticals, Inc. 4,974,662 4,381,992
2021-02-11 13G/A MCRB / Seres Therapeutics, Inc. 5,624,990 5,823,603
2021-02-11 13G PRLB / Proto Labs, Inc. 1,590,665
2021-02-11 13G/A MTLS / Materialise NV - Depositary Receipt (Common Stock) 2,667,051 2,655,198
2021-02-11 13G/A SSYS / Stratasys Ltd. 5,458,115 4,152,236
2021-02-11 13G TREE / LendingTree, Inc. 1,141,653
2021-02-11 13G/A ONVO / Organovo Holdings, Inc. 12,807,832 478,570
2021-02-11 13G PD / PagerDuty, Inc. 6,359,550
2021-02-11 13G/A CRSP / CRISPR Therapeutics AG 3,049,553 3,836,823
2021-02-11 13G/A VCYT / Veracyte, Inc. 3,053,251 3,272,038
2021-02-11 13G/A NSTG / NanoString Technologies, Inc. 1,920,550 1,330,140
2021-02-11 13G/A NVTA / Invitae Corporation 10,057,040 11,255,614
2021-02-11 13G CLXT / Calyxt Inc 2,275,265
2021-02-11 13G/A CGEN / Compugen Ltd. 8,149,982 7,028,228
2021-02-11 13G/A EDIT / Editas Medicine, Inc. 4,948,227 4,388,143
2021-02-11 13G/A NTLA / Intellia Therapeutics, Inc. 5,423,218 5,104,362
2021-02-11 13G/A EB / Eventbrite, Inc. 3,868,354 0
2021-02-11 13G/A INO / Inovio Pharmaceuticals, Inc. 5,047,608 0
2021-02-11 13G/A US3021041047 / ExOne Co 1,611,681 1,457,036
2021-02-11 13G/A CERS / Cerus Corporation 9,765,054 11,103,210
2021-02-11 13G/A LC / LendingClub Corporation 5,852,428 4,548,260
2021-02-11 13G/A TWOU / 2U, Inc. 4,181,193 6,272,370
2020-12-08 13G/A NTLA / Intellia Therapeutics, Inc. 7,178,520 5,423,218
2020-10-08 13G/A NSTG / NanoString Technologies, Inc. 3,830,602 1,920,550
2020-09-08 13G/A MCRB / Seres Therapeutics, Inc. 8,273,223 5,624,990
2020-02-12 13G/A CGEN / Compugen Ltd. 7,319,568 8,149,982
2020-02-12 13G TWOU / 2U, Inc. 4,181,193
2020-02-12 13G LC / LendingClub Corporation 5,852,428
2020-02-12 13G CERS / Cerus Corporation 9,765,054
2020-02-12 13G US3021041047 / ExOne Co 1,611,681
2020-02-12 13G CRSP / CRISPR Therapeutics AG 3,049,553
2020-02-12 13G/A EB / Eventbrite, Inc. 2,857,679 3,868,354
2020-02-12 13G/A NSTG / NanoString Technologies, Inc. 3,904,451 3,830,602
2020-02-12 13G INO / Inovio Pharmaceuticals, Inc. 5,047,608
2020-02-12 13G ONVO / Organovo Holdings, Inc. 12,807,832
2020-02-12 13G/A EDIT / Editas Medicine, Inc. 4,958,593 4,948,227
2020-02-12 13G MTLS / Materialise NV - Depositary Receipt (Common Stock) 2,667,051
2020-02-12 13G/A SYRS / Syros Pharmaceuticals, Inc. 4,305,724 4,974,662
2020-02-12 13G/A SSYS / Stratasys Ltd. 5,457,537 5,458,115
2020-02-12 13G VCYT / Veracyte, Inc. 3,053,251
2020-02-12 13G/A NTLA / Intellia Therapeutics, Inc. 6,442,885 7,178,520
2020-02-12 13G/A MCRB / Seres Therapeutics, Inc. 7,098,097 8,273,223
2020-01-08 13G NVTA / Invitae Corporation 10,057,040
2019-10-09 13G EDIT / Editas Medicine, Inc. 4,958,593
2019-10-09 13G SSYS / Stratasys Ltd. 5,457,537
2019-10-09 13G NSTG / NanoString Technologies, Inc. 3,904,451
2019-09-06 13G SYRS / Syros Pharmaceuticals, Inc. 4,305,724
2019-09-06 13G CGEN / Compugen Ltd. 7,319,568
2019-09-06 13G MCRB / Seres Therapeutics, Inc. 7,098,097
2019-08-06 13G/A EB / Eventbrite, Inc. 2,026,779 2,857,679
2019-08-06 13G/A NTLA / Intellia Therapeutics, Inc. 5,161,098 6,442,885
2019-07-09 13G NTLA / Intellia Therapeutics, Inc. 5,161,098
2019-05-09 13G/A EB / Eventbrite, Inc. 1,274,998 2,026,779
2019-04-09 13G EB / Eventbrite, Inc. 1,274,998